永赢医药创新智选混合发起A(015915)利润分配表
| |
2026-06-30 |
2025-12-31 |
2025-06-30 |
2024-12-31 |
| 收入 |
-245,937,348.65 |
-6,252,284.39 |
464,177,216.05 |
-37,637,062.23 |
| 利息合计 |
1,833,260.26 |
2,636,451.19 |
413,759.64 |
104,677.04 |
| 其中：存款利息收入 |
1,833,260.26 |
2,636,451.19 |
413,759.64 |
104,677.04 |
| 债券利息收入 |
- |
- |
- |
- |
| 资产支持证券利息收入 |
- |
- |
- |
- |
| 买入返售金融资产收入 |
- |
- |
- |
- |
| 投资收益合计 |
57,293,240.69 |
165,779,820.26 |
78,471,420.78 |
-46,411,293.94 |
| 其中：股票投资收益 |
45,286,628.05 |
158,477,714.19 |
75,894,669.60 |
-47,383,322.70 |
| 基金投资收益 |
- |
- |
- |
- |
| 债券投资收益 |
- |
29,689.91 |
29,689.91 |
45,335.50 |
| 资产支持证券投资收益 |
- |
- |
- |
- |
| 衍生工具收益 |
- |
- |
- |
- |
| 股利收益 |
12,006,612.64 |
7,272,416.16 |
2,547,061.27 |
926,693.26 |
| 基金分红收益收益 |
- |
- |
- |
- |
| 公允价值变动收益 |
-329,103,199.66 |
-258,258,195.05 |
359,402,831.64 |
6,977,661.80 |
| 其他收入 |
24,039,350.06 |
83,589,639.21 |
25,889,203.99 |
1,691,892.87 |
| 费用 |
48,395,909.95 |
61,353,300.40 |
9,390,824.33 |
3,816,536.59 |
| 管理人报酬 |
36,705,043.47 |
45,991,477.96 |
6,936,637.44 |
2,738,389.82 |
| 基金托管费 |
1,529,376.80 |
1,916,311.56 |
289,026.56 |
114,099.52 |
| 销售服务费 |
9,959,355.51 |
13,113,755.40 |
2,065,627.91 |
797,982.83 |
| 交易费用 |
- |
- |
- |
- |
| 利息支出 |
- |
2,042.78 |
2,042.78 |
1,135.92 |
| 其中：卖出回购金融资产支出 |
- |
2,042.78 |
2,042.78 |
1,135.92 |
| 其他费用 |
202,134.17 |
329,712.70 |
97,489.64 |
164,928.50 |
| 利润总额 |
-294,333,258.60 |
-67,605,584.79 |
454,786,391.72 |
-41,453,598.82 |
微信公众号
证券之星APP
基本资料
